EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world study.
- DOI
- 10.1016/j.lungcan.2026.109348
- Published
- 2026 May
- Container
- Lung cancer (Amsterdam, Netherlands)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2026.109348,
title = {EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world study.},
author = {Lin SH and Kahangire DA and Nagar SP and Ahn MJ and Affi R and Agulnik J and Shih JY and Hochmair MJ and Tufman A and Debieuvre D and Chow J and Jimenez M and Davis KL and Sandelin M and Veluswamy RR},
year = {2026},
journal = {Lung cancer (Amsterdam, Netherlands)},
doi = {10.1016/j.lungcan.2026.109348},
url = {https://doi.org/10.1016/j.lungcan.2026.109348}
}RIS
TY - JOUR TI - EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world study. AU - Lin SH AU - Kahangire DA AU - Nagar SP AU - Ahn MJ AU - Affi R AU - Agulnik J AU - Shih JY AU - Hochmair MJ AU - Tufman A AU - Debieuvre D AU - Chow J AU - Jimenez M AU - Davis KL AU - Sandelin M AU - Veluswamy RR PY - 2026 JO - Lung cancer (Amsterdam, Netherlands) DO - 10.1016/j.lungcan.2026.109348 UR - https://doi.org/10.1016/j.lungcan.2026.109348 ER -
APA
SH, L., DA, K., SP, N., MJ, A., R, A., J, A., JY, S., MJ, H., A, T., D, D., J, C., M, J., KL, D., M, S., & RR, V. (2026). EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world study.. Lung cancer (Amsterdam, Netherlands). https://doi.org/10.1016/j.lungcan.2026.109348
Source records
- pubmed · retrieved 2026-09-26T22:58:49.146Z
- europe-pmc · retrieved 2026-09-26T22:58:49.155Z